Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This phase Ib/II, single arm, open label, multicenter study is conducted to evaluate the
efficacy and safety of linperlisib in combination with CHOP for newly diagnosed PTCL
patients, and explore the reasonable dosage of linperlisib when combined with CHOP regimen.